Bone Mineral Density (BMD): What It Measures & Why It Matters

Understanding BMD

Bone Mineral Density (BMD) quantifies the amount of mineral (primarily calcium hydroxyapatite) per unit area of bone. It is the primary metric for diagnosing osteoporosis and assessing fracture risk.

Measurement

  • Unit: g/cm² (areal density) via DXA (Dual-energy X-ray Absorptiometry).
  • Sites: Lumbar spine (L1–L4), femoral neck, total hip, forearm (1/3 radius).
  • Results: T-score (vs. young adult peak) and Z-score (vs. age-matched).

WHO Classification (Postmenopausal Women & Men ≥50)

  • Normal: T-score ≥ -1.0
  • Osteopenia (Low Bone Mass): T-score -1.0 to -2.5
  • Osteoporosis: T-score ≤ -2.5
  • Severe Osteoporosis: T-score ≤ -2.5 + fragility fracture

Clinical Significance

  • Each 1 SD decrease in T-score ≈ 1.5–2x increase in fracture risk.
  • Guides treatment initiation (bisphosphonates, denosumab, anabolics).
  • Monitored every 1–2 years on therapy.

BMD ≠ bone quality (microarchitecture, turnover), but remains the standard clinical tool.

Healthcare Management - Related Articles